80TiP Global phase III study of NUC-1031 plus cisplatin vs gemcitabine plus cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121). - Knox, J.J.; McNamara, M.G.; Goyal, L.; Doherty, M.; Cosgrove, D.; Springfeld, C.; Sjoquist, K.; Park, J.O.; Verdaguer, H.; Braconi, C.; Ross, P.; De Gramont, A.; et al. (Annals of Oncology, 2020)